[Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].

Firmin N, Ryckewaert T, Amouyel T, Tetreau R, Gaillard F, Llacer C, Vinches M, Delfour C, Penel N

Open source

DOI
10.1016/j.bulcan.2026.07.012
Published
2026 Sep 17
Container
Bulletin du cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bulcan.2026.07.012,
  title = {[Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].},
  author = {Firmin N and Ryckewaert T and Amouyel T and Tetreau R and Gaillard F and Llacer C and Vinches M and Delfour C and Penel N},
  year = {2026},
  journal = {Bulletin du cancer},
  doi = {10.1016/j.bulcan.2026.07.012},
  url = {https://doi.org/10.1016/j.bulcan.2026.07.012}
}

RIS

TY  - JOUR
TI  - [Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].
AU  - Firmin N
AU  - Ryckewaert T
AU  - Amouyel T
AU  - Tetreau R
AU  - Gaillard F
AU  - Llacer C
AU  - Vinches M
AU  - Delfour C
AU  - Penel N
PY  - 2026
JO  - Bulletin du cancer
DO  - 10.1016/j.bulcan.2026.07.012
UR  - https://doi.org/10.1016/j.bulcan.2026.07.012
ER  - 

APA

N, F., T, R., T, A., R, T., F, G., C, L., M, V., C, D., & N, P. (2026). [Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2026.07.012

Source records